Annual Current Liabilities
$1.78 M
-$558.00 K-23.87%
December 31, 2023
Summary
- As of February 7, 2025, SCNI annual total current liabilities is $1.78 million, with the most recent change of -$558.00 thousand (-23.87%) on December 31, 2023.
- During the last 3 years, SCNI annual current liabilities has fallen by -$18.18 million (-91.08%).
- SCNI annual current liabilities is now -91.08% below its all-time high of $19.96 million, reached on December 1, 2020.
Performance
SCNI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$1.39 M
-$280.00 K-16.75%
September 1, 2024
Summary
- As of February 7, 2025, SCNI quarterly total current liabilities is $1.39 million, with the most recent change of -$280.00 thousand (-16.75%) on September 1, 2024.
- Over the past year, SCNI quarterly current liabilities has dropped by -$533.00 thousand (-27.69%).
- SCNI quarterly current liabilities is now -93.62% below its all-time high of $21.82 million, reached on September 1, 2021.
Performance
SCNI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
SCNI Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.9% | -27.7% |
3 y3 years | -91.1% | -40.5% |
5 y5 years | -69.3% | -40.5% |
SCNI Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -27.2% | at low | -79.5% | at low |
5 y | 5-year | -91.1% | at low | -93.6% | +4.2% |
alltime | all time | -91.1% | +586.2% | -93.6% | +454.1% |
Scinai Immunotherapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $1.39 M(-16.7%) |
Jun 2024 | - | $1.67 M(-13.1%) |
Mar 2024 | - | $1.93 M(+8.1%) |
Dec 2023 | $1.78 M(-23.9%) | $1.78 M(+15.7%) |
Sep 2023 | - | $1.54 M(-18.5%) |
Jun 2023 | - | $1.89 M(-26.8%) |
Mar 2023 | - | $2.58 M(+10.3%) |
Dec 2022 | $2.34 M(-4.3%) | $2.34 M(+58.9%) |
Sep 2022 | - | $1.47 M(-78.3%) |
Jun 2022 | - | $6.77 M(+153.4%) |
Mar 2022 | - | $2.67 M(+9.4%) |
Dec 2021 | $2.44 M(-87.8%) | - |
Dec 2021 | - | $2.44 M(-88.8%) |
Sep 2021 | - | $21.82 M(+2.4%) |
Jun 2021 | - | $21.31 M(+6.7%) |
Mar 2021 | - | $19.98 M(+0.1%) |
Dec 2020 | $19.96 M(+264.6%) | $19.96 M(+517.1%) |
Sep 2020 | - | $3.23 M(+75.5%) |
Jun 2020 | - | $1.84 M(+38.0%) |
Mar 2020 | - | $1.34 M(-75.6%) |
Dec 2019 | $5.47 M | $5.47 M(+521.5%) |
Sep 2019 | - | $881.00 K(-68.5%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $2.80 M(-40.9%) |
Mar 2019 | - | $4.74 M(-18.1%) |
Dec 2018 | $5.79 M(+192.3%) | $5.79 M(+670.7%) |
Sep 2018 | - | $751.00 K(+30.6%) |
Jun 2018 | - | $574.90 K(-78.3%) |
Mar 2018 | - | $2.65 M(+33.6%) |
Dec 2017 | $1.98 M(+454.0%) | $1.98 M(+122.9%) |
Sep 2017 | - | $888.50 K(+67.3%) |
Jun 2017 | - | $531.00 K(+50.6%) |
Mar 2017 | - | $352.70 K(-1.3%) |
Dec 2016 | $357.50 K(-17.9%) | $357.50 K(+42.3%) |
Sep 2016 | - | $251.20 K(-16.1%) |
Jun 2016 | - | $299.30 K(-28.0%) |
Mar 2016 | - | $415.50 K(-4.5%) |
Dec 2015 | $435.20 K(-6.5%) | $435.20 K(+28.7%) |
Sep 2015 | - | $338.20 K(-12.6%) |
Jun 2015 | - | $387.10 K(-6.3%) |
Mar 2015 | - | $413.00 K(-11.3%) |
Dec 2014 | $465.60 K(-9.0%) | $465.60 K(+18.0%) |
Sep 2014 | - | $394.50 K(-22.9%) |
Dec 2013 | $511.70 K(+97.3%) | $511.70 K |
Dec 2012 | $259.40 K | - |
FAQ
- What is Scinai Immunotherapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual current liabilities year-on-year change?
- What is Scinai Immunotherapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly current liabilities year-on-year change?
What is Scinai Immunotherapeutics annual total current liabilities?
The current annual current liabilities of SCNI is $1.78 M
What is the all time high annual current liabilities for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual total current liabilities is $19.96 M
What is Scinai Immunotherapeutics annual current liabilities year-on-year change?
Over the past year, SCNI annual total current liabilities has changed by -$558.00 K (-23.87%)
What is Scinai Immunotherapeutics quarterly total current liabilities?
The current quarterly current liabilities of SCNI is $1.39 M
What is the all time high quarterly current liabilities for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly total current liabilities is $21.82 M
What is Scinai Immunotherapeutics quarterly current liabilities year-on-year change?
Over the past year, SCNI quarterly total current liabilities has changed by -$533.00 K (-27.69%)